Presentations

Documents

Order by : Name | Date | Hits | [ Ascendant ]

Dietary counselling focusing only on fructose consumption improves hepatic inflammation in... Dietary counselling focusing only on fructose consumption improves hepatic inflammation in...

hot!
Date added: 08/06/2018
Date modified: 08/06/2018
Filesize: 1.94 MB
Downloads: 476

"Dietary counselling focusing only on fructose consumption improves hepatic inflammation in patients with NAFLD - a prospective, controlled, randomized open-label study (NUCES NASH)"

Poster presentation given by UMC at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017

Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened pheno.. Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened pheno..

hot!
Date added: 12/31/2018
Date modified: 12/31/2018
Filesize: 256 Bytes
Downloads: 473

"Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD"

Poster presentation given by CNR at the 24th National Congress of Digestive Diseases: Italian Federation of Societies of Digestive Diseases (FISMAD), Rome, Italy, 15th March 2018

Increased hepatic glucose production and insulin resistance in subjects with Non-Alcoholic Fatty... Increased hepatic glucose production and insulin resistance in subjects with Non-Alcoholic Fatty...

hot!
Date added: 03/10/2018
Date modified: 03/10/2018
Filesize: 2.19 MB
Downloads: 472

"Increased hepatic glucose production and insulin resistance in subjects with Non-Alcoholic Fatty Liver Disease is associated to increased plasma concentrations of gluconeogenic amino acids"

Poster presentation given by UNITO & CNR at the EASL International Liver Congress (ILC), Amsterdam, Netherlands, 19th - 23rd April 2017

Study design to validate biomarkers of therapeutic response in NASH due to cirrhosis Study design to validate biomarkers of therapeutic response in NASH due to cirrhosis

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 256 Bytes
Downloads: 472

Oral presentation given by UMC at the 3rd International Workshop on NASH Biomarkers, Washington DC, USA, 18th - 19th May 2018

Which patients will we be treating in 2020 and how will pharmacotherapy be tailored? Which patients will we be treating in 2020 and how will pharmacotherapy be tailored?

hot!
Date added: 01/19/2019
Date modified: 01/19/2019
Filesize: 4.98 MB
Downloads: 470

Oral presentation given by UNITO at the EASL International Liver Congress, Paris, France, 11th - 15th April 2018

European NAFLD Consortia: EPoS, LITMUS & The European NAFLD Registry European NAFLD Consortia: EPoS, LITMUS & The European NAFLD Registry

hot!
Date added: 08/10/2019
Date modified: 08/10/2019
Filesize: 256 Bytes
Downloads: 469

Presentation given by UNEW at the EASL International Liver Congress, Vienna, Austria, 10th - 14th April 2019

A mouse model with inducible ablation of TGFβ receptor type 2 limited to hepatic stellate cells... A mouse model with inducible ablation of TGFβ receptor type 2 limited to hepatic stellate cells...

hot!
Date added: 08/06/2018
Date modified: 08/06/2018
Filesize: 1.52 MB
Downloads: 468

"A mouse model with inducible ablation of TGFβ receptor type 2 limited to hepatic stellate cells predicts the power of HSC-specific TGFβ pathway inhibition"

Poster presentation given by UMC at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017

Diagnostic tools to assess fibrosis in practice and clinical trials Diagnostic tools to assess fibrosis in practice and clinical trials

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 256 Bytes
Downloads: 462

Oral presentation given by UMC at Digestive Disease Week (DDW), Washington DC, USA, 2nd - 5th June 2018

Metabolomics Metabolomics

hot!
Date added: 02/13/2019
Date modified: 02/13/2019
Filesize: 256 Bytes
Downloads: 461

Oral presentation given by CNR at the International Symposium: “Biomarkers for Personalized Hepatology”, Pisa, Italy, 30th May 2018

Disruption of hepatic IL-1 signaling improves insulin sensitivity and hepatic inflammation in a... Disruption of hepatic IL-1 signaling improves insulin sensitivity and hepatic inflammation in a...

hot!
Date added: 08/06/2018
Date modified: 08/06/2018
Filesize: 1.91 MB
Downloads: 460

"Disruption of hepatic IL-1 signaling improves insulin sensitivity and hepatic inflammation in a model of non-alcoholic fatty liver disease (NAFLD)"

Poster presentation given by UMC at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), Washington DC, USA, 20th - 24th October 2017